Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Mundipharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (114)
ARTG (99)
Australian public assessment report (AusPar) (9)
Prescription medicine registration (2)
Cancellation or suspension (1)

Date

2024 (16)
2023 (1)
2022 (62)
2021 (3)
2020 (28)
2019 (5)
2018 (7)
2017 (19)
2016 (11)
2015 (8)
2014 (8)
2013 (14)
2012 (1)
2011 (2)
2010 (7)
2005 (6)
2003 (3)
2001 (3)
2000 (7)
1999 (4)
1996 (1)
1995 (3)
1994 (1)
1993 (3)
1991 (2)

Search

Sponsor content

225 result(s) found, displaying 21 to 30

MPL- OXYCODONE/NALOXONE oxycodone hydrochloride / naloxone hydrochloride 40/20 mg modified release tablet blister pack (288270)

17 October 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MPL- OXYCODONE/NALOXONE oxycodone hydrochloride / naloxone hydrochloride 40/20 mg modified release tablet blister pack.
MPL- OXYCODONE/NALOXONE oxycodone hydrochloride / naloxone hydrochloride 60/30 mg modified release tablet blister pack (288271)

17 October 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MPL- OXYCODONE/NALOXONE oxycodone hydrochloride / naloxone hydrochloride 60/30 mg modified release tablet blister pack.
MPL- OXYCODONE/NALOXONE oxycodone hydrochloride / naloxone hydrochloride 10/5 mg modified release tablets blister pack (288266)

17 October 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MPL- OXYCODONE/NALOXONE oxycodone hydrochloride / naloxone hydrochloride 10/5 mg modified release tablets blister pack.
MPL- OXYCODONE/NALOXONE oxycodone hydrochloride / naloxone hydrochloride 20/10 mg modified release tablet blister pack (288268)

17 October 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MPL- OXYCODONE/NALOXONE oxycodone hydrochloride / naloxone hydrochloride 20/10 mg modified release tablet blister pack.
MPL- OXYCODONE/NALOXONE oxycodone hydrochloride / naloxone hydrochloride 5/2.5 mg modified release tablet blister pack (288265)

17 October 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MPL- OXYCODONE/NALOXONE oxycodone hydrochloride / naloxone hydrochloride 5/2.5 mg modified release tablet blister pack.
AusPAR: Eligard

14 March 2023

Australian public assessment report (AusPar)

AusPAR for Eligard (Leuprorelin acetate) for the treatment of children with central precocious puberty (CPP).
Mundicare Itch Relief Gel Cancelled under Section 30(1)(c) of the Act

16 November 2022

Cancellation by sponsor

Requested by Mundipharma Pty Ltd
Mundicare Itch Relief Spray Cancelled under Section 30(1)(c) of the Act

16 November 2022

Cancellation by sponsor

Requested by Mundipharma Pty Ltd
Tolmar Australia Pty Ltd - Hypodermic needle, single-use, sterile Cancelled under Section 41GL(d) of the Act

6 October 2022

Cancellation by sponsor

Requested by Mundipharma Pty Ltd
Tolmar Australia Pty Ltd - Needle, hypodermic Cancelled under Section 41GL(d) of the Act

6 October 2022

Cancellation by sponsor

Requested by Mundipharma Pty Ltd

Pages

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.